- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04569474
Peripheral IV Dressing and Phlebitis in Patients From Amazon (IVDRESAMAZON)
September 25, 2020 updated by: Mavilde da Luz Gonçalves Pedreira, Federal University of São Paulo
Efficacy of Sterile Dressing in the Prevention of of Peripheral Intravenous Catheters Associated Phlebitis in Patients From the Western Brazilian Amazon: Pragmatic, Randomized, Blinded and Controlled Trail
Pragmatic, randomized, single-blinded, controlled clinical trial of the effect of dressing and stabilization of peripheral intravenous catheters on the occurrence of phlebitis in adult patients attended at a hospital from the Western Brazilian Amazon.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Peripheral venous catheterization is the most commonly performed invasive procedure in healthcare.
Care practices and the use of technologies may influence the results of the use peripheral intravenous catheters (PIC), contributing to the reduction of complications and adverse events.
Phlebitis is characterized as one of the most serious complication related to the use of PIC and this study has as hypothesis to analyze if the occurrence of phlebitis associated with PIC is influenced by the use of sterile dressing.
Objectives: To verify the effect of using sterile dressing and sterile adhesive tape compared to non-sterile adhesive tape in PIC on the occurrence of phlebitis in adult patients attended at a hospital from the Western Brazilian Amazon.
Methods: Pragmatic, randomized, controlled and single-blinded clinical study conducted in Rio Branco, Acre.
The sample was calculated in 330 patients, aged 18 years or older and who met the inclusion criteria.
Data collection took place between June 2018 and September 2019, after approval of ethical merit.
To identify the type of sterile transparent dressing to be studied, was carried out an implementation study with a final sample of 71 patients, focusing analysis from the perspective of the patient, professional and clinics.
The patients of the clinical study were randomly allocated to one of the study groups: Experimental group (sterile transparent dressing) or Standard Group (non-sterile adhesive tape).
Phlebitis was diagnosed by the bedside nurse, according to presence and severity.
If present, the nurse removed the CIP and an external evaluator was called to perform a diagnose of phlebitis with blindness regarding the intervention.
Variables related to patient characterization, intravenous therapy, peripheral venipuncture, reasons for withdrawal and length of PIC stay, reasons for removal and length of coverage, and associated complications were investigated.
For the statistical analysis, Chi-square, Fisher's Exact, student t test, and Mann-Whitney U tests were used.
The multiple analysis was performed using the logistic regression model to estimate the Relative Risk (RR) and the Kaplan-Meier model, Cox regression, for survival analysis.
RR calculation for 95% Confidence Interval (IC) was applied to estimate the degree of association between variables.
In all tests, the significance level of 5% was considered.
Study Type
Interventional
Enrollment (Actual)
330
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
São Paulo, Brazil, 04024002
- Federal University of São Paulo
-
São Paulo, Brazil, 04024002
- Universidade Federal de São Paulo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- IV access for more 48 hours obtained in the studied wards.
- IV access 20 and 22 G.
- without confusion or agitation
- Aged more or equal 18 years
Exclusion Criteria:
- Sepsis
- Skin lesions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Dressing Group
use of sterile transparent dressing
|
Use of sterile transparente dressing
|
NO_INTERVENTION: Standard Group
non-sterile transparente dressing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Phlebitis
Time Frame: Unitl day 7 of catheter placement and study participation
|
Vein inflamation measure by Scale Grades from Infusion Nursing Society rating from zero (absence) to 4 (severe phlebitis)
|
Unitl day 7 of catheter placement and study participation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mavilde LG Pedreira, PhD, Full Professor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 6, 2018
Primary Completion (ACTUAL)
September 10, 2019
Study Completion (ACTUAL)
July 6, 2020
Study Registration Dates
First Submitted
April 2, 2018
First Submitted That Met QC Criteria
September 25, 2020
First Posted (ACTUAL)
September 29, 2020
Study Record Updates
Last Update Posted (ACTUAL)
September 29, 2020
Last Update Submitted That Met QC Criteria
September 25, 2020
Last Verified
September 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2198630
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Phlebitis
-
Cukurova UniversityCompleted
-
William Beaumont HospitalsWithdrawnPeripheral Intravenous Vein Catheter Phlebitis | Intravenous InfectionUnited States
-
Assistance Publique - Hôpitaux de ParisUnknownVein Infusion PhlebitisFrance
-
University of Health Sciences LahoreNot yet recruitingPatient With IV Cannula Induce Phlebitis
-
William Beaumont HospitalsRecruitingPeripheral Intravenous Vein Catheter Phlebitis | Intravenous InfectionUnited States
-
Federal University of São PauloCompleted
-
Kahramanmaras Sutcu Imam UniversityCompleted
-
Royal Brisbane and Women's HospitalUnknown
-
Hospital Universitario Marqués de ValdecillaRecruiting
Clinical Trials on Transparent dressing
-
Children's Hospital of Eastern OntarioThe Physicians' Services Incorporated FoundationCompleted
-
Yuksek Ihtisas HospitalCompletedNewborn | Peripheral Venous CatheterizationTurkey
-
SerenaGroup, Inc.DrySee, IncCompleted
-
Vomaris InnovationsCompletedBurns | Wound HealingUnited States
-
3MUniversity of NebraskaCompletedCatheterization
-
Columbia UniversityCompletedCentral Line Complication | Neonatal DiseaseUnited States
-
3MTerminatedCatheter-Related Infections | Central Venous Catheter Exit Site InfectionChina
-
Affiliated Hospital to Academy of Military Medical...RecruitingEndoscopic Retrograde Cholangiopancreatography | Biliary Tract Neoplasms | Biliary Disease | Bile Duct StrictureChina
-
Brigham and Women's HospitalMemorial Sloan Kettering Cancer Center; Massachusetts General HospitalRecruitingPersonal Protective EquipmentUnited States